Analysis of pathway network built upon co-expression of GPNMB points that it serves as a bridging factor, which is common for the pathophysiology of OP and COPD, responsive to RANKL and possibly targetable either through RANKL or through MYC, or both. This evidence concerns the gene MYC and chronic obstructive pulmonary disease.